Search

everythinglearnresearchcommunity

for

Search:↓

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Gene variation affects prostate issues and hair loss.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

CEC levels may be a useful marker for predicting prostate cancer progression.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Some breast cancer patients on hormone therapy experience hair loss, and treatments like certain topical inhibitors and supplements may help without harming their cancer prognosis.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.